Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
American Journal of Obstetrics and Gynecology
|
October 6, 2009
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
Elisabeth Wik, Jone Trovik, Ole E Iversen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 4, 2013
GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer
Konstantinos Doufekas, Richard Hadwin, Raju Kandimalla, et al.
Plos One
|
July 17, 2025
Immunohistochemistry guided segmentation of benign epithelial cells, in situ lesions, and invasive epithelial cells in breast cancer slides
Maren Høibø, André Pedersen, Vibeke Grotnes Dale, et al.
Plos One
|
March 4, 2014
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer
Henrica M J Werner, Jone Trovik, Mari K Halle, et al.
Nature Communications
|
June 22, 2023
Hypoxia induced responses are reflected in the stromal proteome of breast cancer
Silje Kjølle, Kenneth Finne, Even Birkeland, et al.
Journal of Clinical Pathology
|
September 11, 2016
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival
Tor A Klingen, Ying Chen, Ingunn M Stefansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2011
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
Jone Trovik, Elisabeth Wik, Ingunn M Stefansson, et al.
BMC Cancer
|
May 8, 2012
Lipocalin 2 expression is associated with aggressive features of endometrial cancer
Monica Mannelqvist, Ingunn M Stefansson, Elisabeth Wik, et al.
The Journal of Pathology. Clinical Research
|
October 13, 2019
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
Hilde Ytre-Hauge Smeland, Cecilie Askeland, Elisabeth Wik, et al.
Oncotarget
|
October 21, 2015
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
Geir Bredholt, Monica Mannelqvist, Ingunn M Stefansson, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
American Journal of Obstetrics and Gynecology
|
October 6, 2009
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
Elisabeth Wik, Jone Trovik, Ole E Iversen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 4, 2013
GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer
Konstantinos Doufekas, Richard Hadwin, Raju Kandimalla, et al.
Plos One
|
July 17, 2025
Immunohistochemistry guided segmentation of benign epithelial cells, in situ lesions, and invasive epithelial cells in breast cancer slides
Maren Høibø, André Pedersen, Vibeke Grotnes Dale, et al.
Plos One
|
March 4, 2014
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer
Henrica M J Werner, Jone Trovik, Mari K Halle, et al.
Nature Communications
|
June 22, 2023
Hypoxia induced responses are reflected in the stromal proteome of breast cancer
Silje Kjølle, Kenneth Finne, Even Birkeland, et al.
Journal of Clinical Pathology
|
September 11, 2016
Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival
Tor A Klingen, Ying Chen, Ingunn M Stefansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2011
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer
Jone Trovik, Elisabeth Wik, Ingunn M Stefansson, et al.
BMC Cancer
|
May 8, 2012
Lipocalin 2 expression is associated with aggressive features of endometrial cancer
Monica Mannelqvist, Ingunn M Stefansson, Elisabeth Wik, et al.
The Journal of Pathology. Clinical Research
|
October 13, 2019
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
Hilde Ytre-Hauge Smeland, Cecilie Askeland, Elisabeth Wik, et al.
Oncotarget
|
October 21, 2015
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses
Geir Bredholt, Monica Mannelqvist, Ingunn M Stefansson, et al.
Page
of 7